Search Results

You are looking at 111 - 120 of 1,575 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Revisiting the Association of ECOG Performance Status With Clinical Outcomes in Diverse Patients With Cancer

Deepika Kumar, Elad Neeman, Shiyun Zhu, Hongxin Sun, Dinesh Kotak, and Raymond Liu

electronic health records (EHRs). Demographic and clinical characteristics as of the index date were obtained from the EHRs, including age, sex, race/ethnicity, marital status, type of insurance, primary spoken language, body mass index, neighborhood

Full access

HSR20-111: Characteristics, Treatment Patterns, Healthcare Resource Use and Costs among Pediatric Patients Diagnosed with Neurofibromatosis Type 1 and Plexiform Neurofibromas: A Retrospective Database Analysis

Xiaoqin Yang, Kaushal Desai, Neha Agrawal, Kirti Mirchandani, Sagnik Chatterjee, Eric Sarpong, and Shuvayu Sen

describe the characteristics, treatment patterns, healthcare resource use (HRU) and costs for these patients. ​ Methods: A retrospective study of individuals enrolled in the MarketScan ® Commercial Claims and Encounters claims database from 10

Full access

HSR20-097: Granulocyte Stimulating Colony Factor Use, Characteristics and Treatment Patterns in the United States: An Updated Analysis by the Biologics and Biosimilars Collective Intelligence Consortium

Catherine Lockhart, Cara McDermott, James Marshall, Aaron Mendelsohn, Pamala Pawloski, and Jeffrey Brown

. Objective: To evaluate patient characteristics and treatment use patterns in patients treated with GCSFs. This analysis will help inform a large-scale, real-world, observational GCSF comparative effectiveness research (CER) study using the Biologics

Full access

EPR23-083: Non-Squamous, Metastatic Non–Small Cell Lung Cancer: Retrospective c-Met Overexpression Testing, Patient Characteristics, and Treatment Patterns

Mona H. Cai, Yookyung Christy Choi, Athan Vasilopoulos, Alexander Liede, Sidney S. Lindsey, Leon Raskin, Ethan Truong, Jeremy Fricke, Stephen B. Gruber, and Peter J. Ansell

-Met OE negative (NEG) were less likely to be Asian (14% vs 30%, respectively), more likely to be diagnosed with stage IV disease (57% vs 41%), and more likely to be PD-L1 POS (78% vs 41%). All other observed characteristics were similar between groups

Full access

HSR20-089: Association of Patient Clinico-Genomic Characteristics With Tumor Mutational Burden in Small Cell Lung Cancer: An Observational Study

Sumesh Kachroo, Changxia Shao, Kaushal Desai, Jinghua He, Fan Jin, and Shuvayu Sen

Background: This study evaluated the relationship between patients’ clinical and genomic characteristics and high tumor mutational burden (TMB) in the context of small cell lung cancer (SCLC). Methods: This was a retrospective cohort study using

Full access

Mental Health and Chemical Dependency Services at US Cancer Centers

Shehzad K. Niazi, Aaron Spaulding, Emily Brennan, Sarah K. Meier, Julia E. Crook, Lauren F. Cornell, Sikander Ailawadhi, Matthew M. Clark, and Teresa A. Rummans

Social Security Act) were invited to participate in the survey. The database contains information about hospital characteristics, services offered, and staffing, and responses are validated through review, comparison, and member checking by the AHA. 41

Full access

Receipt of Screening Mammography by Insured Women Diagnosed With Breast Cancer and Impact on Outcomes

Marissa B. Lawson, Christoph I. Lee, Daniel S. Hippe, Shasank Chennupati, Catherine R. Fedorenko, Kathleen E. Malone, Scott D. Ramsey, and Janie M. Lee

addition, we used the following ICD codes to identify patients with screening encounters: Z12.31, V76.11, and V76.12. Statistical Analysis We compared clinical and tumor characteristics between women diagnosed with cancer who received screening

Full access

Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma

Jordan M. Cloyd, Chengli Shen, Heena Santry, John Bridges, Mary Dillhoff, Aslam Ejaz, Timothy M. Pawlik, and Allan Tsung

,500 Commission on Cancer–accredited facilities. Jointly sponsored by the American College of Surgeons and American Cancer Society, it currently captures more than 70% of newly diagnosed cancers within the United States. Relevant patient characteristics, tumor

Full access

Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy

Matthew J. Townsend, Mofei Liu, Anita Giobbie-Hurder, Jordan S. Sack, Nicole R. LeBoeuf, F. Stephen Hodi, Julia McNabb-Baltar, and Shilpa Grover

≥2 of 3 criteria were met: (1) abdominal pain consistent with AP, (2) serum lipase ≥3 times the upper limit of normal (ULN), and (3) characteristic imaging findings. 11 Serum lipase, not amylase, was our primary laboratory marker, given its greater

Full access

Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines

Angela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, Marina Deuker, Franciska Stolzenbach, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Anil Kapoor, Cristian Fiori, Francesco Porpiglia, and Pierre I. Karakiewicz

data can provide further detail regarding the distribution of patient and renal cell carcinoma (RCC) characteristics within this special patient group. Based on these considerations, we reexamined patients with RCC with T1a 0- to 2-cm renal tumors to